ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
PMGC Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.83+0.06 (+2.17%)
Close on Oct 19, 2026
- Market cap
- $13.80M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1,650.74 (−99.83%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
PMGC Holdings Inc. reported revenue of $2.58M for the twelve months to Jun 30, 2026. Free cash flow was -$6.38M.
Revenue
$2.58M
TTM Q2 2026
Free cash flow
-$6.38M
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $13.80M
- P/E ratio
- –
- Price to sales
- 5.35
- Price to book
- 0.82
- Dividend yield
- –
- Free cash flow yield
- -46.20%
Fundamentals
- Revenue
- $2.58M
- Net income
- -$13.49M
- Free cash flow
- -$6.38M
- Book value per share
- $3.43
- Diluted shares
- 5M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$2.58M
Gross profit
$801.48K
Net income
-$13.49M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months